Hodgkin Lymphoma Program
Meet our team
At the Hodgkin Lymphoma Program, we have a staff of compassionate and experienced pediatric subspecialists that includes oncologists, radiation oncologists, radiologists and surgeons. Our physicians are focused on family-centered care: From your first visit, you’ll work with a team of professionals who are committed to supporting all of your family’s physical and psychosocial needs.
Amy L. Billett, MD
Billett is a pediatric oncologist and has worked at DF/CHCC for more than 20 years. She specializes in the treatment of lymphomas including Hodgkin disease, non-Hodgkin lymphoma and Burkitt’s lymphoma. She also oversees patient safety and quality for the Division of Hematology and Oncology. She is an associate professor of pediatrics at Harvard Medical School.
Kirsten Ecklund, MD
Ecklund has worked at Children’s since 1994. A pediatric radiology who specializes in diagnostic radiology and pediatric musculoskeletal radiology, she holds the vice chair of Diagnostic Radiology and the Chief of the Division of Diagnostic Radiology. She is also an assistant professor of radiology at Harvard Medical School.
Mark Daniel Fleming, MD, DPhil
Fleming is a hematopathologist and Children’s pathologist-in-chief. He specializes diagnosis of cancers of the blood and lymph systems. His research focuses on iron metabolism in the blood. He’s also an Associate Professor of Pathology at Harvard Medical School.
Frederick D. Grant, MD
Grant is a radiologist specializing in nuclear medicine and molecule imaging. His research focuses on applications of nuclear medicine to pediatric oncology. He is also an instructor in radiology at Harvard Medical School.
Karen J. Marcus, MD
Marcus joined DF/CHCC in 1989 and specializes in pediatric oncology and radiation oncology. She treats children with a wide variety of cancers including brain tumors, sarcomas, neuroblastoma, leukemias, kidney tumors and Hodgkin lymphoma. She’s an associate professor at Harvard Medical School and co-chair of Pediatric Oncology Institutional Review Board.
Robert C. Shamberger, MD
Shamberger is Children’s Chief of Surgery and has expertise in surgical oncology. He is a professor of Surgery at Harvard Medical School. His research focuses on the treatment of neuroblastoma, Ewing’s sarcoma, Wilms’ tumor and inflammatory bowel disease.
Stephan D. Voss, MD, PhD
Voss is a staff radiologist and researcher at Children’s. His research focuses on developing new methods for imaging malignant disease, specifically pediatric neuroblastoma. In addition, he is an assistant professor of radiology at Harvard Medical School.
Christopher Weldon, MD, PhD
Weldon is a pediatric general surgeon with expertise in pediatric oncology and surgical critical care. His research focuses on chemotherapy resistance in solid tumors. He is also an instructor at Harvard Medical School.